These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34165964)

  • 1. Magneto-Activation and Magnetic Resonance Imaging of Natural Killer Cells Labeled with Magnetic Nanocomplexes for the Treatment of Solid Tumors.
    Sim T; Choi B; Kwon SW; Kim KS; Choi H; Ross A; Kim DH
    ACS Nano; 2021 Aug; 15(8):12780-12793. PubMed ID: 34165964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-guided interventional natural killer cell delivery for liver tumor treatment.
    Su Z; Wang X; Zheng L; Lyu T; Figini M; Wang B; Procissi D; Shangguan J; Sun C; Pan L; Qin L; Zhang B; Velichko Y; Salem R; Yaghmai V; Larson AC; Zhang Z
    Cancer Med; 2018 May; 7(5):1860-1869. PubMed ID: 29601672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model.
    Sheu AY; Zhang Z; Omary RA; Larson AC
    Invest Radiol; 2013 Jun; 48(6):492-9. PubMed ID: 23249649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation.
    Li K; Gordon AC; Zheng L; Li W; Guo Y; Sun J; Zhang G; Han G; Larson AC; Zhang Z
    Nanomedicine (Lond); 2015; 10(11):1761-74. PubMed ID: 26080698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial Engineered Natural Killer Cells Combined with Antiheat Endurance as a Powerful Strategy for Enhancing Photothermal-Immunotherapy Efficiency of Solid Tumors.
    Zhang D; Zheng Y; Lin Z; Lan S; Zhang X; Zheng A; Li J; Liu G; Yang H; Liu X; Liu J
    Small; 2019 Oct; 15(42):e1902636. PubMed ID: 31468667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
    Hosseinzadeh F; Ai J; Ebrahimi-Barough S; Seyhoun I; Hajifathali A; Muhammadnejad S; Hosseinzadeh F; Shadnoush M; Dabiri Oskouei F; Verdi J
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3797-3803. PubMed ID: 31870124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.
    Kamiya T; Chang YH; Campana D
    Cancer Immunol Res; 2016 Jul; 4(7):574-81. PubMed ID: 27197065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma.
    Zhuang L; Fulton RJ; Rettman P; Sayan AE; Coad J; Al-Shamkhani A; Khakoo SI
    Hepatol Int; 2019 Jan; 13(1):75-83. PubMed ID: 30467624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live cell imaging of highly activated natural killer cells against human hepatocellular carcinoma in vivo.
    Uong TNT; Yoon MS; Lee KH; Hyun H; Nam TK; Min JJ; Nguyen HPQ; Kim SK
    Cytotherapy; 2021 Sep; 23(9):799-809. PubMed ID: 34176769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
    Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
    Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer.
    Kennedy PR; Felices M; Miller JS
    Stem Cell Res Ther; 2022 Apr; 13(1):165. PubMed ID: 35414042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory Magnetic Microspheres for Augmenting Tumor-Specific Infiltration of Natural Killer (NK) Cells.
    Park W; Gordon AC; Cho S; Huang X; Harris KR; Larson AC; Kim DH
    ACS Appl Mater Interfaces; 2017 Apr; 9(16):13819-13824. PubMed ID: 28406012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors.
    Khodayari H; Khodayari S; Ebrahimi E; Hadjilooei F; Vesovic M; Mahmoodzadeh H; Saric T; Stücker W; Van Gool S; Hescheler J; Nayernia K
    Cancer Immunol Immunother; 2021 Dec; 70(12):3369-3395. PubMed ID: 34218295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
    Shi L; Lin H; Li G; Sun Y; Shen J; Xu J; Lin C; Yeh S; Cai X; Chang C
    Cancer Lett; 2016 Apr; 373(1):45-56. PubMed ID: 26805759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.
    Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z
    Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
    Hu W; Wang G; Huang D; Sui M; Xu Y
    Front Immunol; 2019; 10():1205. PubMed ID: 31214177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialic acid-engineered mesoporous polydopamine dual loaded with ferritin gene and SPIO for achieving endogenous and exogenous synergistic T2-weighted magnetic resonance imaging of HCC.
    Fan K; Lu C; Shu G; Lv XL; Qiao E; Zhang N; Chen M; Song J; Wu F; Zhao Z; Xu X; Xu M; Chen C; Yang W; Sun J; Du Y; Ji J
    J Nanobiotechnology; 2021 Mar; 19(1):76. PubMed ID: 33731140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
    Sung PS; Jang JW
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches.
    Yu M; Li Z
    Front Med; 2017 Dec; 11(4):509-521. PubMed ID: 28780700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.